Tmc435350 PowerPoint PPT Presentations
All Time
Recommended
Partnership with Tibotec / Johnson & Johnson since November 2004. Phase Ia/b completed ... Paraesthesia. Photosensitivity. 11. TMC435350 Phase Ib Completed ...
| PowerPoint PPT presentation | free to view
Dept of Infectious Diseases/HIV Medicine, Royal Free Hospital ... Boceprevir (Schering-Plough) TMC435350 (Tibotec & Medivir) Nucleoside polymerase inhibitor ...
| PowerPoint PPT presentation | free to view
HIV:HCV Co-infection Landscape 21 of October, 09 Madrid,Spain GESIDA, Madrid HCV Protease Inhibitor R7227 HCV Protease Inhibitors Telaprevir and Boceprevir protease ...
| PowerPoint PPT presentation | free to download
Increased Side Effects. Or will we have to wait for IFN and/or RBV sparing regimens? ... ART use at Baseline in the PARADIGM Study (US/Spain/Portugal) NRTIs ...
| PowerPoint PPT presentation | free to view
for Hepatitis B, C and delta. Department of Virology & INSERM U955 ... Pruritus. Anemia. SPRINT-1 Trial (Naive, Gen 1) PEG-IFN 2b, 1.5 mg/kg/wk. 0. 48. 24. 12 ...
| PowerPoint PPT presentation | free to view
Hepatitis Liver transplantation ... 1) Tzakis AG et al., Transplantation 1990;49:354-358 ... Impact of HIV on survival after liver transplantation in the HAART era ...
| PowerPoint PPT presentation | free to view
Liver biopsy: grade and stage ... Degree of liver damage. Psychological factors. Other ... Liver disease accounts for 43% of deaths in HIV infected patients ...
| PowerPoint PPT presentation | free to view
Medivir's late preclinical projects Bertil Samuelsson, VP Discovery Research ... Business model and R&D day summary Lars Adlersson, CEO Medivir AB ...
| PowerPoint PPT presentation | free to view
